{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T06:52:17Z","timestamp":1710399137463},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n<jats:title>Background &amp; Aims:<\/jats:title>\n<jats:p>Hepatocellular carcinoma (HCC) is the fifth most common cancer\nand the second leading cause of cancer-related deaths. The only definitive treatment for both HCC\nand cirrhosis is liver transplantation, but long wait times in some regions and a relatively fixed\nnumber of donor organs negatively impact access to liver transplantation. The aim of the work was\nto evaluate and compare the short outcome of patients with medium-sized HCC who will undergo\npercutaneous microwave ablation (MWA) alone and in combination with TACE.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This prospective study included 40 patients with medium-sized HCC lesions who were\nclassified into two groups; Group A that included twenty patients treated by TACE followed by percutaneous\nMWA after 2 weeks and group B that included twenty patients treated by 2 sessions of\npercutaneous MWA with 2 weeks interval. Full history taking, clinical examination, laboratory investigation,\nabdominal ultrasonography and abdominal tri-phasic computed tomography (CT) with\ncontrast were obtained from the two groups. Laboratory and radiological follow up of the cases\nwere done at 1 and 3 months after the treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>There was no statistically significant difference in the sociodemographic criteria, laboratory\nmeasurement and clinical criteria between the cases in the two study groups before initiation of\ntreatment. The response was slightly better in the combined treatment group, but it did not show a\nstatistically significant difference. The incidence of complications was higher in the MWA group.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>Hepatocellular carcinoma is a common complication of HCV related cirrhosis. Association\nof TACE-MWA led to better response rates than MWA with fewer complications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568009622666220117094146","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T16:32:26Z","timestamp":1642523546000},"page":"77-85","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Transarterial Chemoembolization with Microwave Ablation\nversus Microwave Alone for Treatment of Medium Sized Hepatocellular\nCarcinoma"],"prefix":"10.2174","volume":"22","author":[{"given":"Waleed","family":"El-Agawy","sequence":"first","affiliation":[{"name":"Tropical Medicine Department, Faculty of Medicine, Port-Said University, Port Fouad, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Ahmed","family":"El-Ganainy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine,\nTanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy Abd Almawgoud","family":"Gad","sequence":"additional","affiliation":[{"name":"Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of\nMedicine, Benha University, Benha, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherief","family":"Abd-Elsalam","sequence":"additional","affiliation":[{"name":"Tropical Medicine and Infectious Diseases Department, Tanta University,\nTanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wessam Abd Alltaif","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Radiology Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed El-Sayed","family":"El-Shewi","sequence":"additional","affiliation":[{"name":"Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of\nMedicine, Benha University, Benha, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.3748\/wjg.v23.i29.5282","volume":"23","author":"Dimitroulis D.","year":"2017","unstructured":"Dimitroulis D.; Damaskos C.; Valsami S.; Davakis S.; Garmpis N.; Spartalis E.; Athanasiou A.; Moris D.; Sakellariou S.; Kykalos S.; Tsourouflis G.; Garmpi A.; Delladetsima I.; Kontzoglou K.; Kouraklis G.; From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017,23(29),5282-5294","journal-title":"World J Gastroenterol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"El-Serag H.B.","year":"2012","unstructured":"El-Serag H.B.; Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012,142(6),1264-1273","journal-title":"Gastroenterology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/ejim.ejim_29_18","volume":"30","author":"Elgamal S.","year":"2018","unstructured":"Elgamal S.; Ghafar A.A.; Ghoneem E.; Elshaer M.; Alrefai H.; Elemshaty W.; Characterization of patients with hepatocellular carcinoma on the way for early detection: one center experience. Egypt J Intern Med 2018,30(4),231-238","journal-title":"Egypt J Intern Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/00365521.2014.1003397","volume":"50","author":"Abdelaziz A.O.","year":"2015","unstructured":"Abdelaziz A.O.; Nabeel M.M.; Elbaz T.M.; Shousha H.I.; Hassan E.M.; Mahmoud S.H.; Rashed N.A.; Ibrahim M.M.; Abdelmaksoud A.H.; Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: Prospective analysis. Scand J Gastroenterol 2015,50(4),479-484","journal-title":"Scand J Gastroenterol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s11605-011-1716-2","volume":"15","author":"Kuang M.","year":"2011","unstructured":"Kuang M.; Xie X-Y.; Huang C.; Wang Y.; Lin M-X.; Xu Z-F.; Liu G.J.; Lu M.D.; Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma. J Gastrointest Surg 2011,15(12),2165-2171","journal-title":"J Gastrointest Surg"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s00464-014-3617-4","volume":"28","author":"Abdelaziz A.","year":"2014","unstructured":"Abdelaziz A.; Elbaz T.; Shousha H.I.; Mahmoud S.; Ibrahim M.; Abdelmaksoud A.; Nabeel M.; Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: An Egyptian multidisciplinary clinic experience. Surg Endosc 2014,28(12),3429-3434","journal-title":"Surg Endosc"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.7314\/APJCP.2014.15.9.3915","volume":"15","author":"Abdelaziz A.O.","year":"2014","unstructured":"Abdelaziz A.O.; Elbaz T.M.; Shousha H.I.; Ibrahim M.M.; Rahman El-Shazli M.A.; Abdelmaksoud A.H.; Aziz O.A.; Zaki H.A.; Elattar I.A.; Nabeel M.M.; Survival and prognostic factors for hepatocellular carcinoma: An Egyptian multidisciplinary clinic experience. Asian Pac J Cancer Prev 2014,15(9),3915-3920","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/hepr.12100","volume":"44","author":"Tanaka M.","year":"2014","unstructured":"Tanaka M.; Ando E.; Simose S.; Hori M.; Kuraoka K.; Ohno M.; Yutani S.; Harada K.; Sata M.; Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma. Hepatol Res 2014,44(2),194-200","journal-title":"Hepatol Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jvir.2014.10.047","volume":"26","author":"Ginsburg M.","year":"2015","unstructured":"Ginsburg M.; Zivin S.P.; Wroblewski K.; Doshi T.; Vasnani R.J.; Van Ha T.G.; Comparison of combination therapies in the management of hepatocellular carcinoma: Transarterial chemoembolization with radiofrequency ablation versus microwave ablation. J Vasc Interv Radiol 2015,26(3),330-341","journal-title":"J Vasc Interv Radiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"Bruix J.","year":"2011","unstructured":"Bruix J.; Sherman M.; Management of hepatocellular carcinoma: An update. Hepatology 2011,53(3),1020-1022","journal-title":"Hepatology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2214\/AJR.05.1286","volume":"188","author":"Minami Y.","year":"2007","unstructured":"Minami Y.; Kudo M.; Chung H.; Kawasaki T.; Yagyu Y.; Shimono T.; Shiozaki H.; Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007,188(2),489-494","journal-title":"AJR Am J Roentgenol"},{"key":"ref=12","first-page":"2235","volume":"28","author":"Ma Y.","year":"2008","unstructured":"Ma Y.; Zhang X.; Li X.; Zhang L.; Su H.; Zhan C.; Value of computed tomography and magnetic resonance imaging in diagnosis and differential diagnosis of small hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 2008,28(12),2235-2238","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref=13","first-page":"189","volume":"18","author":"Abdelaziz A.O.","year":"2017","unstructured":"Abdelaziz A.O.; Abdelmaksoud A.H.; Nabeel M.M.; Shousha H.I.; Cordie A.A.; Mahmoud ShH.; Medhat E.; Omran D.; Elbaz T.M.; Transarterial chemoembolization combined with either radiofrequency or microwave ablation in management of hepatocellular carcinoma. Asian Pac J Cancer Prev 2017,18(1),189-194","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=14","first-page":"1094","volume":"31","author":"EI-Edel RH","year":"2018","unstructured":"EI-Edel RH; Tawfik GA; Noreldin RI; El-Jaky MA; Eisaa DA; Evaluation of serum Midkine as a novel marker in hepatocellular carcinomas. Menoufia Med J 2018,31(3),1094","journal-title":"Menoufia Med J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"146389","DOI":"10.1155\/2015\/146389","volume":"2015","author":"Shaheen K.Y.","year":"2015","unstructured":"Shaheen K.Y.; Abdel-Mageed A.I.; Safwat E.; AlBreedy A.M.; The value of serum midkine level in diagnosis of hepatocellular carcinoma. Int J Hepatol 2015,2015,146389","journal-title":"Int J Hepatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.21608\/aeji.2020.25284.1054","volume":"10","author":"Abozaid S.R.","year":"2020","unstructured":"Abozaid S.R.; Elshamy M.H.; Alazim A.A.; Elhawari S.A.; Microwave ablation and\/or transcatheter arterial chemo-embolization in the treatment of hepatocellular carcinoma. AJIED 2020,10(4),407-416","journal-title":"AJIED"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00261-018-1464-9","volume":"43","author":"Smolock A.R.","year":"2018","unstructured":"Smolock A.R.; Cristescu M.M.; Hinshaw A.; Woo K.M.; Wells S.A.; Ziemlewicz T.J.; Lubner M.G.; Dalvie P.S.; Louis Hinshaw J.; Brace C.L.; Ozkan O.S.; Lee F.T.; Laeseke P.; Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. Abdom Radiol (NY) 2018,43(9),2497-2504","journal-title":"Abdom Radiol (NY)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/jgh.12088","volume":"28","author":"Xu L.F.","year":"2013","unstructured":"Xu L.F.; Sun H.L.; Chen Y.T.; Ni J.Y.; Chen D.; Luo J.H.; Zhou J.X.; Hu R.M.; Tan Q.Y.; Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol 2013,28(3),456-463","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=19","first-page":"1158","volume":"62","author":"Mazure N.M.","year":"2002","unstructured":"Mazure N.M.; Chauvet C.; Bois-Joyeux B.; Bernard M-A.; Nacer-Ch&#xE9;rif H.; Danan J-L.; Repression of &#x3B1;-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: Characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res 2002,62(4),1158-1165","journal-title":"Cancer Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jhep.2011.11.020","volume":"56","author":"Memon K.","year":"2012","unstructured":"Memon K.; Kulik L.; Lewandowski R.J.; Wang E.; Ryu R.K.; Riaz A.; Nikolaidis P.; Miller F.H.; Yaghmai V.; Baker T.; Abecassis M.; Benson A.B.; Mulcahy M.F.; Omary R.A.; Salem R.; Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis. J Hepatol 2012,56(5),1112-1120","journal-title":"J Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"85599","DOI":"10.18632\/oncotarget.20343","volume":"8","author":"He C.","year":"2017","unstructured":"He C.; Zhang X.; Li C.; Peng W.; Wen T-F.; Yan L-N.; Yang J.; Lu W.; Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization. Oncotarget 2017,8(49),85599-85611","journal-title":"Oncotarget"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"C217","DOI":"10.4103\/0973-1482.200598","volume":"12","author":"Li W.","year":"2016","unstructured":"Li W.; Man W.; Guo H.; Yang P.; Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma. J Cancer Res Ther 2016,12(7)(Suppl.),C217-C220","journal-title":"J Cancer Res Ther"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1148\/radiology.220.2.r01au44420","volume":"220","author":"Goldberg S.N.","year":"2001","unstructured":"Goldberg S.N.; Saldinger P.F.; Gazelle G.S.; Huertas J.C.; Stuart K.E.; Jacobs T.; Kruskal J.B.; Percutaneous tumor ablation: Increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Radiology 2001,220(2),420-427","journal-title":"Radiology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.jvir.2008.08.028","volume":"19","author":"Mostafa E.M.","year":"2008","unstructured":"Mostafa E.M.; Ganguli S.; Faintuch S.; Mertyna P.; Goldberg S.N.; Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. J Vasc Interv Radiol 2008,19(12),1740-1748","journal-title":"J Vasc Interv Radiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3892\/ol.2021.12815","volume":"22","author":"Guo J.","year":"2021","unstructured":"Guo J.; Wang S.; Han Y.; Jia Z.; Wang R.; Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma. Oncol Lett 2021,22(1),554","journal-title":"Oncol Lett"},{"key":"ref=26","first-page":"471","volume":"26","author":"Liu H-C.","year":"2014","unstructured":"Liu H-C.; Shan E-B.; Zhou L.; Jin H.; Cui P-Y.; Tan Y.; Lu Y.M.; Combination of percutaneous radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: observation of clinical effects. Chin J Cancer Res 2014,26(4),471-477","journal-title":"Chin J Cancer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0284185115603246","volume":"57","author":"Bharadwaz A.","year":"2016","unstructured":"Bharadwaz A.; Bak-Fredslund K.P.; Villadsen G.E.; Nielsen J.E.; Simonsen K.; Sandahl T.D.; Gr&#xF8;nb&#xE6;k H.; Nielsen D.T.; Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: Experience from a Danish tertiary liver center. Acta Radiol 2016,57(7),844-851","journal-title":"Acta Radiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.7314\/APJCP.2015.16.14.6159","volume":"16","author":"Xu C.","year":"2015","unstructured":"Xu C.; Lv P-H.; Huang X-E.; Wang S-X.; Sun L.; Wang F-A.; Efficacy of transarterial chemoembolization combined with radiofrequency ablation in treatment of hepatocellular carcinoma. Asian Pac J Cancer Prev 2015,16(14),6159-6162","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.clinre.2015.07.008","volume":"40","author":"Chen Q-W.","year":"2016","unstructured":"Chen Q-W.; Ying H-F.; Gao S.; Shen Y-H.; Meng Z-Q.; Chen H.; Chen Z.; Teng W.J.; Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2016,40(3),309-314","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e68453","DOI":"10.1371\/journal.pone.0068453","volume":"8","author":"Liao M.","year":"2013","unstructured":"Liao M.; Huang J.; Zhang T.; Wu H.; Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: A meta-analysis. PLoS One 2013,8(7),e68453","journal-title":"PLoS One"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2006-941442","volume":"23","author":"Clark T.W.I.","year":"2006","unstructured":"Clark T.W.I.; Complications of hepatic chemoembolization. Semin Intervent Radiol 2006,23(2),119-125","journal-title":"Semin Intervent Radiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1007\/s00330-011-2222-3","volume":"21","author":"Bertot L.C.","year":"2011","unstructured":"Bertot L.C.; Sato M.; Tateishi R.; Yoshida H.; Koike K.; Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: A systematic review. Eur Radiol 2011,21(12),2584-2596","journal-title":"Eur Radiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.4254\/wjh.v7.i25.2578","volume":"7","author":"Poggi G.","year":"2015","unstructured":"Poggi G.; Tosoratti N.; Montagna B.; Picchi C.; Microwave ablation of hepatocellular carcinoma. World J Hepatol 2015,7(25),2578-2589","journal-title":"World J Hepatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3109\/02656736.2011.605099","volume":"27","author":"Liu C.","year":"2011","unstructured":"Liu C.; Liang P.; Liu F.; Wang Y.; Li X.; Han Z.; Liu C.; MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Int J Hyperthermia 2011,27(7),654-662","journal-title":"Int J Hyperthermia"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MEG.0000000000000790","volume":"29","author":"Negm O.","year":"2017","unstructured":"Negm O.; Abou Saif S.; El Gharib M.; Yousef M.; Abd-Elsalam S.; Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2017,29(3),317-321","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"OC32","DOI":"10.7860\/JCDR\/2017\/23095.9450","volume":"11","author":"Watany M.","year":"2017","unstructured":"Watany M.; Badawi R.; Elkhalawany W.; Abd-Elsalam S.; Study of Dickkopf-1 (DKK-1) Gene Expression in Hepatocellular Carcinoma Patients. J Clin Diagn Res 2017,11(2),OC32-OC34","journal-title":"J Clin Diagn Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/02656736.2018.1424946","volume":"34","author":"Abdelfattah A.A.M.","year":"2018","unstructured":"Abdelfattah A.A.M.; Rizk F.; Hawash N.; Hanafy A.; El-Kalla F.; Abd-Elsalam S.; Randomized trial of preoperative administration of oral pregabalin for postoperative analgesia in patients scheduled for radiofrequency ablation of focal lesions in the liver. Int J Hyperthermia 2018,34(8),1367-1371","journal-title":"Int J Hyperthermia"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2174\/1568009619666190718141647","volume":"19","author":"El-Gebaly F.","year":"2019","unstructured":"El-Gebaly F.; Abou-Saif S.; Elkadeem M.; Helmy A.; Abd-Elsalam S.; Yousef M.; Elkhouly R.A.; Amer I.F.; El-Demerdash T.; Study of serum soluble programmed death ligand 1 as a prognostic factor in hepatocellular carcinoma in Egyptian patients. Curr Cancer Drug Targets 2019,19(11),896-905","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1875318302010010069","volume":"10","author":"Badawi R.","year":"2020","unstructured":"Badawi R.; Soliman H.; Ziada D.; Serum markers as a predictor of hepatic fibrosis compared to fibroscan in chronic hepatitis B infected Egyptian patients: A cross-sectional study. Open Biomark J 2020,10,69-75","journal-title":"Open Biomark J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1875318302010010015","volume":"10","author":"Mohamed A.A.","year":"2020","unstructured":"Mohamed A.A.; El-Toukhy N.; Ghaith D.M.; Talin-1 gene expression as a tumor marker in hepatocellular carcinoma patients: A pilot study. Open Biomark J 2020,10,15-22","journal-title":"Open Biomark J"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568009622666220117094146","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200257\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568009622666220117094146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T07:27:33Z","timestamp":1654759653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200257\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009622666220117094146","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}